Literature DB >> 7245438

A rapid microchromatographic method for determination of hemoglobin AI.

O Wålinder.   

Abstract

Hemoglobin AI (HbAI) is a minor hemoglobin fraction, which is continuously formed by a glycosylation reaction throughout the life-span of the erythrocyte. The concentration of HbAI reflects the average blood glucose level during the preceding 1 - 2 months and HbAI-determinations have been found to be of value in long-term diabetes control. A simple and reliable microchromatographic method for HbAI-determinations, suitable for routine clinical analyses, is described. In a group of diabetic patients (n = 126) the mean (+ S.D.) S.D.) HbAI--value was 9.6 + 1.8%, in the reference group (n = 33) the corresponding value was 6.0 + 0.8%. A commercial kit (Bio-Rad) based on the same principle was compared with our method. It was of equal accuracy and gave comparable results.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7245438     DOI: 10.3109/03009738009179182

Source DB:  PubMed          Journal:  Ups J Med Sci        ISSN: 0300-9734            Impact factor:   2.384


  1 in total

1.  Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial.

Authors:  J Fagius; A Brattberg; S Jameson; C Berne
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.